Advertisement

Topics

Ascletis, Inc. Company Profile

16:21 EST 19th February 2019 | BioPortfolio

Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China’s capital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases. For more information, please visit http://www.ascletis.com.


News Articles [50 Associated News Articles listed on BioPortfolio]

Ascletis's IND Filing for Third HCV Treatment Accepted in China

Ascletis Pharma of Hangzhou reported that China's NMPA accepted its filing for an investigational new drug application (IND) of its third HCV drug, ASC21. Ascletis said ASC21 has shown potent, pan-gen...

Roche partners a second product with Ascletis in China

In their second deal together, Ascletis Pharma Inc. gained another drug candidate from Roche (via Shanghai Roche Pharmaceuticals Ltd.), this time the antiviral hepatitis B and C agent Pegasys (peginte...

Ascletis and Alphamab sign licensing agreement for Anti─PD─L1 to treat hepatitis B and other viral diseases

Ascletis Pharma Inc and Suzhou Alphamab Co, Ltd. jointly announced that Ascletis' subsidiary and Alphamab have entered into a strategic collaboration and exclusive licensing agreement for anti─PD─...

Ascletis Acquires China Marketing Rights to Roche's Pegylated Interferon

Ascletis BioScience of Hangzhou acquired exclusive sales and marketing rights to Pegasys, a Shanghai Roche pegylated interferon used to treat hepatitis B and C. Lindi Tan, PhD and CFO of Ascletis, tol...

Hong Kong biotech IPOs face lower valuations after Ascletis flop

Biotechs taking an advantage of new Hong Kong exchange rules have been told to expect lower valuations, after Chinese pioneer Ascletis Pharma’s shares plunged nearly 45% in the first month of tradin...

Ascletis's Second HCV Treatment on Priority Review List in China

Ascletis Pharma of Hangzhou reported that its second hepatitis C treatment, ravidasvir, has been included in China's list of Proposed Priority Review drugs. Ascletis has submitted an NDA for ravidasvi...

Hong Kong biotechs IPOs face lower valuations after Ascletis flop

Biotechs taking an advantage of new Hong Kong exchange rules have been told to expect lower valuations, after Chinese pioneer Ascletis Pharma’s shares plunged nearly 45% in the first month of tradin...

Ascletis Acquires China Rights to Alphamab's PD-L1 for Hepatitis B

Ascletis Pharma of Hangzhou acquired China rights to a Suzhou Alphamab anti-PD-L1 candidate for hepatitis B and other viral disease indications. Ascletis will make an upfront payment, and Alphamab wil...

Drugs and Medications [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Ascletis, Inc.

Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new...

More Information about "Ascletis, Inc." on BioPortfolio

We have published hundreds of Ascletis, Inc. news stories on BioPortfolio along with dozens of Ascletis, Inc. Clinical Trials and PubMed Articles about Ascletis, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ascletis, Inc. Companies in our database. You can also find out about relevant Ascletis, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record